This market snapshot from Life Science Intelligence provides an analysis of the global market for oncology embolization agents, including radioembolization, chemoembolization and particle embolization devices. These solutions are used to occlude blood vessels to lesions and tumors to derive the target of nutrients, enhance the effectiveness of the targeted delivery of pharmaceuticals, and trigger cell death.
This market snapshot is intended to provide a high-level overview of the global oncology embolization agents market, with key insights into:
ABK Biomedical
Arsenal Medical
Boston Scientific
Cook
Cordis/Cardinal Health
Instylla
Medtronic
Merit Medical
Ned Medical
Obsidio
SirTex Medical
Stryker
Terumo
Varian
Trusted By The Companies Pioneering What’s Next
Market Intelligence
Schedule an exploratory call
Request Info17011 Beach Blvd, Suite 500 Huntington Beach, CA 92647
714-847-3540© 2024 Life Science Intelligence, Inc., All Rights Reserved. | Privacy Policy